BTK inhibitors

3D rendering of platelets
Biotech

Sanofi BTK inhibitor for blood disease raises platelet levels

Patients receiving the drug also saw meaningful improvements in physical fatigue and bleeding compared to the placebo group.
Darren Incorvaia Nov 5, 2024 1:42pm
positive negative up down good bad mixed

Sanofi lifts lid on data behind tolebrutinib’s mixed MS studies

Sep 20, 2024 7:07am
plan B fail reroute road path trail miss

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

Sep 2, 2024 1:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Sanofi nails phase 3 LUNA landing, sparking race to regulators

Apr 23, 2024 2:23am
ducks in a row line up follow leader

Novartis lines up another potential indication for BTK inhibitor

Mar 9, 2024 12:00pm
end of the road road block shut down closed blocked

Merck KGaA drops evobrutinib in wake of double phase 3 fail

Mar 7, 2024 9:54am